KeyBanc on West Pharmaceutical (WST): 'We Like Shares on Weakness'; PT Lowered to $325
Tweet Send to a Friend
KeyBanc analyst Paul Knight lowered the price target on West Pharmaceutical (NYSE: WST) to $325.00 (from $470.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
